Recently, a similar finding demonstrated that Se-methylselenocysteine inhibited HIF-1α in renal cell carcinoma through a PHD2-dependent and Von-Hippel-Lindau-independent degradation mechanism 37. The gene discussed is EGLN1; the disease is renal cell carcinoma.